Adagio Medical (NASDAQ:ADGM – Get Free Report) and SiBone (NASDAQ:SIBN – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, valuation, analyst recommendations, dividends, earnings, institutional ownership and profitability.
Volatility & Risk
Adagio Medical has a beta of 0.13, suggesting that its stock price is 87% less volatile than the S&P 500. Comparatively, SiBone has a beta of 0.69, suggesting that its stock price is 31% less volatile than the S&P 500.
Valuation & Earnings
This table compares Adagio Medical and SiBone”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Adagio Medical | $266,000.00 | 52.62 | -$75.04 million | ($1.52) | -0.60 |
| SiBone | $193.58 million | 3.81 | -$30.91 million | ($0.51) | -33.33 |
SiBone has higher revenue and earnings than Adagio Medical. SiBone is trading at a lower price-to-earnings ratio than Adagio Medical, indicating that it is currently the more affordable of the two stocks.
Institutional & Insider Ownership
48.1% of Adagio Medical shares are owned by institutional investors. Comparatively, 98.1% of SiBone shares are owned by institutional investors. 5.2% of Adagio Medical shares are owned by company insiders. Comparatively, 4.0% of SiBone shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
Analyst Ratings
This is a breakdown of recent recommendations for Adagio Medical and SiBone, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Adagio Medical | 1 | 0 | 1 | 0 | 2.00 |
| SiBone | 1 | 0 | 5 | 0 | 2.67 |
Adagio Medical presently has a consensus target price of $4.00, indicating a potential upside of 339.56%. SiBone has a consensus target price of $25.00, indicating a potential upside of 47.06%. Given Adagio Medical’s higher possible upside, equities analysts plainly believe Adagio Medical is more favorable than SiBone.
Profitability
This table compares Adagio Medical and SiBone’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Adagio Medical | N/A | -791.01% | -199.58% |
| SiBone | -11.24% | -12.86% | -9.43% |
Summary
SiBone beats Adagio Medical on 9 of the 14 factors compared between the two stocks.
About Adagio Medical
Adagio Medical Holdings, Inc., a developmental stage medical device company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, atrial flutter, and ventricular tachycardia. The company’s product portfolio includes iCLAS atrial ultra-low temperature cryoablation (ULTC) catheter and accessories; vCLAS ventricular ULTC catheter; and Cryopulse atrial pulsed-field cryoablation catheter and accessories. The company is based in Laguna Hills, California.
About SiBone
SI-BONE, Inc., a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; iFuse-TORQ, a set of 3D-printed threaded implants designed to treat pelvic trauma; and iFuse Bedrock Granite implant provides sacroiliac fusion and sacropelvic fixation as a foundational element for segmental spinal fusion. It markets its products primarily with a direct sales force, as well as through agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.
Receive News & Ratings for Adagio Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adagio Medical and related companies with MarketBeat.com's FREE daily email newsletter.
